돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 2222133생성일: 2026년 10월 26일

Sodium hydride → 3-(1-Methyl-2-butynyloxy)-5-(3,5-dimethylpiperidino)-1,2,4-thiadiazole

https://huagongshe.com/reaction/2222133

반응식

참여 물질

역할이름HCID투입량
반응물Sodium hydrideHCID 24758—
반응물3-Pentyn-2-olHCID 141344—
반응물3-Methylsulfinyl-5-(3,5-dimethylpiperidino)-1,2,4-thiadiazoleHCID 69217516—
용매DimethylformamideHCID 6228—
용매tert-Butyl methyl etherHCID 15413—
생성물3-(1-Methyl-2-butynyloxy)-5-(3,5-dimethylpiperidino)-1,2,4-thiadiazoleHCID 5879212996.1%

반응 단계

In 3 ml of N,N-dimethylformamide were dissolved 287 mg of 3-methylsulfinyl-5-(3,5-dimethylpiperidino)-1,2,4-thiadiazole and 103 mg of 3-pentyn-2-ol, and 58 mg of sodium hydride (oil suspension; content: 60 weight %) was added under ice-cooling. The mixture was stirred for 15 minutes and at room temperature for 1.5 hour. Furthermore, 30 mg of sodium hydride (oil suspension; content: 60 weight %) and 100 mg of 3-pentyn-2-ol were added in the mixture, and the mixture was stirred at room temperature for 30 minutes. The reaction mixture was diluted with tert-butyl methyl ether, and extracted with tert-butyl methyl ether after the addition of water. The organic layer was dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was subjected to silica gel column chromatography to obtain 297 mg of 3-(1-methyl-2-butynyloxy)-5-(3,5-dimethylpiperidino)-1,2,4-thiadiazole (hereinafter, referred to as the present compound (21)).

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US07371746B2
출처 데이터셋uspto-grants-2008_05
ORD IDord-b4269e750c6743138312e91d77d4eade
출처 메모uspto-grants-2008_05